← HERBALIFE LTD.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $260.0m | $213.9m | $296.6m | $311.0m | $372.6m | $447.2m | $321.3m | $142.2m | $254.3m | $227.8m | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($500k) | — | |
| Depreciation and amortization | $98.3m | $99.8m | $100.4m | $97.7m | $100.3m | $107.6m | $115.4m | $113.3m | $121.4m | $121.2m | $120.8m | |
| Amortization of Debt Issuance Costs | $7.9m | $8.4m | $7.3m | $5.3m | $4.6m | $6.0m | $6.3m | $7.1m | $7.6m | $7.6m | — | |
| Amortization of Debt Issuance Costs and Discounts | $55.7m | $60.2m | $63.8m | $43.7m | $26.7m | $30.1m | $6.7m | $7.4m | $13.4m | $16.4m | — | |
| Depreciation | $80.7m | $80.1m | $80.8m | $78.8m | $80.9m | $89.2m | $94.3m | $88.9m | $96.5m | $99.4m | $120.8m | |
| Deferred Income Tax Expense (Benefit) | ($36.4m) | $97.8m | ($8.1m) | $15.4m | $2.0m | ($33.3m) | ($29.9m) | ($41.1m) | ($229.6m) | ($64.2m) | ($55.4m) | |
| Share-based Payment Arrangement, Noncash Expense | $40.2m | $42.1m | $35.5m | $38.6m | $51.0m | $54.1m | $44.4m | $48.0m | $50.0m | $44.1m | $42.8m | |
| Goodwill and Intangible Asset Impairment | $0 | $0 | $0 | $0 | $0 | — | $0 | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | $400k | ($57.3m) | $15.7m | — | $24.6m | $12.8m | $1.0m | ($10.5m) | $0 | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Inventories | $71.6m | ($37.9m) | $83.3m | $68.6m | $76.6m | $129.1m | $68.4m | ($57.5m) | $30.4m | $27.9m | ($17.8m) | |
| Inventory Write-down | $15.8m | $20.7m | $17.4m | $19.1m | $20.6m | $28.8m | $38.4m | $28.5m | $18.9m | $25.9m | — | |
| Increase (Decrease) in Accounts Payable | ($1.3m) | ($5.0m) | $21.7m | $100k | $5.5m | $6.9m | ($1.1m) | ($7.4m) | ($14.6m) | $24.1m | $8.1m | |
| Other Operating Income (Expense), Net | — | — | — | $37.5m | $14.5m | $16.4m | $14.9m | $10.2m | $5.5m | $4.8m | — | |
| Net Cash Provided by (Used in) Operating Activities | $367.3m |
$590.8m
+60.85%
|
$648.4m
+9.75%
|
$457.5m
-29.44%
|
$628.6m
+37.40%
|
$460.3m
-26.77%
|
$352.5m
-23.42%
|
$357.5m
+1.42%
|
$285.4m
-20.17%
|
$333.3m
+16.78%
|
$383.8m
+15.15%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $143.4m | $95.5m | $84.0m | $106.1m | $112.0m | $151.4m | $156.4m | $135.0m | $122.0m | $80.4m | ($61.5m) | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | — | — | — | — | — | $25.5m | ($10.0m) | |
| Payments for (Proceeds from) Other Investing Activities | ($2.1m) | $2.3m | ($100k) | $1.9m | $11.2m | $5.0m | ($200k) | ($200k) | $500k | $2.8m | — | |
| Net Cash Provided by (Used in) Investing Activities | ($141.3m) | ($97.8m) | ($83.9m) | ($108.0m) | ($123.2m) | ($156.4m) | ($156.2m) | ($134.8m) | ($84.6m) | ($108.7m) | ($72.1m) | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | ($48.5m) | $0 | $0 | ($24.6m) | $12.8m | $1.0m | ($10.5m) | $0 | — | |
| Payments for Repurchase of Common Stock | $13.2m | $844.2m | $750.3m | $16.7m | $923.5m | $1.0b | $146.7m | $11.0m | $8.3m | $8.2m | — | |
| Payments of Ordinary Dividends, Common Stock | $0 | $0 | $0 | — | — | — | — | — | — | — | — | |
| Proceeds from (Payments for) Other Financing Activities | ($700k) | $2.1m | $3.0m | $3.2m | $3.5m | $4.2m | $4.2m | $3.2m | $2.5m | ($3.1m) | — | |
| Net Cash Provided by (Used in) Financing Activities | ($252.3m) |
($85.2m)
+66.23%
|
($593.1m)
-596.13%
|
($713.0m)
-20.22%
|
($320.9m)
+54.99%
|
($728.6m)
-127.05%
|
($264.7m)
+63.67%
|
($148.3m)
+43.97%
|
($335.3m)
-126.10%
|
($295.5m)
+11.87%
|
($243.8m)
+17.50%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | ($20.1m) | $28.2m | ($80.5m) | ($367.5m) | $206.5m | ($443.6m) | ($94.1m) | $79.2m | ($157.4m) | ($62.8m) | $411.5m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($20.1m) | $28.2m | $1.2b | $847.5m | $1.1b | $610.4m | $516.3m | $595.5m | $438.1m | $375.3m | $411.5m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | ($20.1m) | $28.2m | ($51.9m) | ($4.0m) | $22.0m | ($18.9m) | ($25.7m) | $4.8m | ($22.9m) | $8.1m | ($18.1m) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $45.4m | $100.7m | $106.1m | $114.3m | $78.9m | $143.5m | $133.5m | $159.1m | $194.4m | $205.7m | — | |
| Income Taxes Paid, Net | $162.9m | $158.8m | $158.9m | $147.9m | $138.2m | $156.3m | $144.9m | $133.1m | $146.5m | $116.8m | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($11.4m) | ($13.7m) | ($17.3m) | ($2.0m) | $14.8m | $6.2m | $9.7m | $18.7m | $9.2m | $14.5m | — | |
| General and Administrative Expense | — | — | — | — | — | — | — | — | — | $1.7b | — | |
| Goodwill | $89.9m | $96.9m | $92.9m | $91.5m | $100.5m | $95.4m | $93.2m | $95.4m | $87.7m | $100.5m | $23.0m | |
| Income Tax Expense (Benefit) | $104.7m | $257.3m | $167.6m | $140.4m | $143.8m | $113.6m | $103.5m | $60.8m | ($84.9m) | $47.3m | — | |
| Investment Income, Interest | $5.9m | $14.5m | — | — | — | — | — | — | — | — | — | |
| Restructuring Costs | — | — | — | — | — | — | — | — | $69.1m | $7.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.